Crewe Advisors’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23
Closed -$181 978
2023
Q4
$181 Buy
+23
New +$148 ﹤0.01% 357
2023
Q3
Sell
-13
Closed -$119 768
2023
Q2
$119 Sell
13
-226
-95% -$1.88K ﹤0.01% 843
2023
Q1
$1.78K Hold
239
﹤0.01% 726
2022
Q4
$1.18K Hold
239
﹤0.01% 906
2022
Q3
$2K Hold
239
﹤0.01% 1052
2022
Q2
$1K Buy
+239
New +$1.83K ﹤0.01% 1082

Other funds holding LFST

Crewe Advisors's LFST Position: Q1 2024 in Review

Crewe Advisors sold out of Lifestance Health (LFST) in Q1 2024, closing a stake of 23 shares — an estimated $181 sold.

Crewe Advisors first reported a position in LFST in Q2 2022 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 124 funds tracked by Wall St. Rank hold LFST as of Q1 2024.

  • Crewe Advisors reported no remaining Lifestance Health position as of Q1 2024 after selling out during the quarter.
  • Crewe Advisors sold 23 Lifestance Health shares in Q1 2024, an estimated $181.
  • Crewe Advisors first reported a position in Lifestance Health in Q2 2022 and held it in 6 quarters.
  • Crewe Advisors's Lifestance Health position peaked at $2K in Q3 2022.
  • 124 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2024.

Based on Crewe Advisors's 13F filing for Q1 2024, filed 14 May 2024.